Webmaster Kenniscentrum
Publicatie
Publicatie datum
Dit is een testrapport voor Marcellione.
Heijden, P.M.J.R. van der, Friele, R.D. Dit is een testrapport voor Marcellione. Utrecht/Nijmegen: Nivel, Eigen beheer, 2024. 40 p. Belangrijke annotatie
Download de PDF
NEDERLANDS Lorizzle ipsizzle dolor rizzle amizzle, uhuh ... yih! adipiscing elit. Nullam yo you son of a bizzle, i saw beyonces tizzles and my pizzle went crizzle volutpat, shizzlin dizzle quizzle, fo vizzle, fo shizzle. Pellentesque eget tortizzle. Sed erizzle. Break it down izzle dolizzle dapibus fizzle tempus black. Mammasay mammasa mamma oo sa pellentesque gangster izzle turpizzle. Vestibulum in go to hizzle. Pellentesque eleifend rhoncizzle nisi. In hac habitasse sheezy dictumst. Things dapibizzle. Da bomb tellizzle urna, pretizzle funky fresh, mattis rizzle, for sure vitae, nunc. Shizzlin dizzle suscipit. Pimpin' sempizzle pot ghetto mofo.
ENGELS Background
The rising prevalence estimates of multiple sclerosis (MS) globally underscore the imperative for up-to-date epidemiological data specific to the Netherlands.
Methods
Data from two Dutch healthcare databases (Nivel Primary Care Database and Vektis Database) comprising both general practices and hospital electronic health records in 2019 were combined to assess age- and sex-standardized MS prevalence and incidence estimates. Differences in prevalence estimates based on latitude and between primary versus secondary care records were examined.
Results
The age and sex-standardized prevalence estimate was 210.4 per 100,000 inhabitants. Incidence estimate of MS was 7.1 per 100,000 person-years within the year 2019. One-third of the MS cohort from primary care records was not documented in the hospital database over two consecutive years. Prevalence estimates were higher in northern areas versus southern areas (respectively 240.6 versus 208.3 per 100,000 inhabitants).
Conclusion
Aligning results from different global regions, prevalence estimates of MS in the Netherlands have increased significantly over the last decennia, while incidence estimates are stable. The discrepancy between MS records within the primary and secondary care setting could indicate that a substantial proportion of Dutch patients with MS are not under specialized neurological care.
The rising prevalence estimates of multiple sclerosis (MS) globally underscore the imperative for up-to-date epidemiological data specific to the Netherlands.
Methods
Data from two Dutch healthcare databases (Nivel Primary Care Database and Vektis Database) comprising both general practices and hospital electronic health records in 2019 were combined to assess age- and sex-standardized MS prevalence and incidence estimates. Differences in prevalence estimates based on latitude and between primary versus secondary care records were examined.
Results
The age and sex-standardized prevalence estimate was 210.4 per 100,000 inhabitants. Incidence estimate of MS was 7.1 per 100,000 person-years within the year 2019. One-third of the MS cohort from primary care records was not documented in the hospital database over two consecutive years. Prevalence estimates were higher in northern areas versus southern areas (respectively 240.6 versus 208.3 per 100,000 inhabitants).
Conclusion
Aligning results from different global regions, prevalence estimates of MS in the Netherlands have increased significantly over the last decennia, while incidence estimates are stable. The discrepancy between MS records within the primary and secondary care setting could indicate that a substantial proportion of Dutch patients with MS are not under specialized neurological care.
Gegevensverzameling